Description
This sequence change replaces arginine, which is basic and polar, with proline, which is neutral and non-polar, at codon 102 of the MPL protein (p.Arg102Pro). This variant is present in population databases (rs28928907, gnomAD 0.07%). This missense change has been observed in individual(s) with congenital amegakaryocytic thrombocytopenia (CAMT) (PMID: 971406, 11972523, 16470591, 18240171, 19302922, 21225925, 24119002, 26854587, 28859041). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 14158). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on MPL protein function. Experimental studies have shown that this missense change affects MPL function (PMID: 18422784, 19302922, 24438083, 25538044). This variant disrupts the p.Arg102 amino acid residue in MPL. Other variant(s) that disrupt this residue have been observed in individuals with MPL-related conditions (PMID: 16470591, 21659346), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic.
# | Sample | Method | Observation |
---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences |
---|
1 | germline | unknown | not provided | not provided | not provided | | not provided | not provided | not provided | not provided |